Heidelberg Pharma AG (HPHA) Q4 2023 Earnings Report

5 Followers

DE:HPHA Q4 2023 EPS Results

Actual EPS-€0.10

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€0.14

Actual Revenue€1.27M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth-38.94%

QuarterQ4 2023

Date03/25/2024

TimeBefore Open

Conference CallMonday, March 25, 2024

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Jul 15, 2026	2026 (Q2)	- / 0.02	-0.143	112.59% (+0.16)
Mar 26, 2026	2025 (Q4)	- / -0.09	-0.127	28.35% (+0.04)
Jul 10, 2025	2025 (Q2)	- / -0.14	-0.09	-58.89% (-0.05)
Mar 21, 2025	2024 (Q4)	- / -0.13	-0.096	-32.29% (-0.03)
Oct 03, 2024	2024 (Q3)	- / -	―	―
Jul 11, 2024	2024 (Q2)	- / -0.09	-0.202	55.45% (+0.11)
Mar 25, 2024	2023 (Q4)	- / -0.10	-0.141	31.91% (+0.04)
Oct 12, 2023	2023 (Q3)	- / -	-0.135	―
Jul 13, 2023	2023 (Q2)	- / -0.20	-0.04	-405.00% (-0.16)
Mar 24, 2023	2022 (Q4)	- / -0.14	-0.212	33.49% (+0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed